These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18171316)

  • 1. Uses and safety profile of ciclosporin in ophthalmology.
    Kashani S; Mearza AA
    Expert Opin Drug Saf; 2008 Jan; 7(1):79-89. PubMed ID: 18171316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ciclosporin in the treatment of ocular surface disorders.
    Tatlipinar S; Akpek EK
    Br J Ophthalmol; 2005 Oct; 89(10):1363-7. PubMed ID: 16170133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical ophthalmic cyclosporine: pharmacology and clinical uses.
    Donnenfeld E; Pflugfelder SC
    Surv Ophthalmol; 2009; 54(3):321-38. PubMed ID: 19422961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye.
    Tang-Liu DD; Acheampong A
    Clin Pharmacokinet; 2005; 44(3):247-61. PubMed ID: 15762768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical cyclosporine in ophthalmology: Pharmacology and clinical indications].
    Levy O; Labbé A; Borderie V; Laroche L; Bouheraoua N
    J Fr Ophtalmol; 2016 Mar; 39(3):292-307. PubMed ID: 26997607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclosporin use in dry eye disease patients.
    Ridder WH
    Expert Opin Pharmacother; 2008 Dec; 9(17):3121-8. PubMed ID: 19006483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.
    Daniell M; Constantinou M; Vu HT; Taylor HR
    Br J Ophthalmol; 2006 Apr; 90(4):461-4. PubMed ID: 16547328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
    Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
    J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical cyclosporine for atopic keratoconjunctivitis.
    González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic ciclosporin and tacrolimus in dermatology.
    Madan V; Griffiths CE
    Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease.
    Hoy SM
    Drugs; 2017 Nov; 77(17):1909-1916. PubMed ID: 29110189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis].
    Doan S; Gabison E; Abitbol O; Gatinel D; Chast F; Hoang-Xuan T
    J Fr Ophtalmol; 2007 Sep; 30(7):697-701. PubMed ID: 17878822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-European survey of the topical ocular use of cyclosporine A.
    Labbé A; Baudouin C; Ismail D; Amrane M; Garrigue JS; Leonardi A; Figueiredo FC; Van Setten G; Labetoulle M
    J Fr Ophtalmol; 2017 Mar; 40(3):187-195. PubMed ID: 28318723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation calcineurin inhibitors for ophthalmic indications.
    Anglade E; Yatscoff R; Foster R; Grau U
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1525-40. PubMed ID: 17922618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial.
    Durlik M; Paczek L; Rutkowski B; Lewandowska D; Debska-Slizien A; Chamienia A; Wyzgal J; Ognista-Gajda A; Niemczyk M
    Ann Transplant; 2010; 15(3):51-9. PubMed ID: 20877267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of topical cyclosporin A in ocular graft-versus-host-disease.
    Kiang E; Tesavibul N; Yee R; Kellaway J; Przepiorka D
    Bone Marrow Transplant; 1998 Jul; 22(2):147-51. PubMed ID: 9707022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M).
    Beirão JM; Matos ME; Beirão IB; Costa PP; Torres PA
    Eur J Ophthalmol; 2013; 23(2):156-63. PubMed ID: 23065854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.